These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 7904616
1. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. Kuechle MK, Stegemeir E, Maynard B, Gibson LE, Leiferman KM, Peters MS. J Am Acad Dermatol; 1994 Feb; 30(2 Pt 1):187-92. PubMed ID: 7904616 [Abstract] [Full Text] [Related]
5. A Case of Possible Concurrence of Dermatitis Herpetiformis and Linear Immunoglobulin A / Immunoglobulin G Bullous Dermatosis. Minakawa S, Matsuzaki Y, Hashimoto T, Ishii N, Nishie W, Sawamura D. Acta Dermatovenerol Croat; 2021 Jul; 29(2):116-117. PubMed ID: 34477081 [Abstract] [Full Text] [Related]
6. Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literature. Plunkett RW, Chiarello SE, Beutner EH. J Am Acad Dermatol; 2001 Nov; 45(5):691-6. PubMed ID: 11606917 [Abstract] [Full Text] [Related]
10. Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience. Arbache ST, Nogueira TG, Delgado L, Miyamoto D, Aoki V. An Bras Dermatol; 2014 Nov; 89(6):885-9. PubMed ID: 25387492 [Abstract] [Full Text] [Related]
11. Drug-induced linear IgA bullous dermatosis probably induced by furosemide. Cerottini JP, Ricci C, Guggisberg D, Panizzon RG. J Am Acad Dermatol; 1999 Jul; 41(1):103-5. PubMed ID: 10411419 [Abstract] [Full Text] [Related]
12. A successful challenge in a patient with vancomycin-induced linear IgA dermatosis. Joshi S, Scott G, Looney RJ. Ann Allergy Asthma Immunol; 2004 Jul; 93(1):101-3. PubMed ID: 15281479 [Abstract] [Full Text] [Related]
13. Drug-induced linear immunoglobulin A bullous dermatosis mimicking Stevens-Johnson syndrome: a case report. Cummings JE, Snyder RR, Kelly EB, Raimer SS. Cutis; 2007 Mar; 79(3):203-7. PubMed ID: 17674585 [Abstract] [Full Text] [Related]
14. A subepidermal blistering dermatosis associated with coexistent IgG and IgA anti-dermal basement membrane zone antibodies; demonstration of IgG antibodies reactive against a 200-kDa dermal antigen. Watanabe M, Tsunoda T, Tagami H. Eur J Dermatol; 2002 Mar; 12(6):603-6. PubMed ID: 12459541 [Abstract] [Full Text] [Related]
15. Linear IgA bullous dermatosis associated with vancomycin and disseminated varicella-zoster infection. Ahkami R, Thomas I. Cutis; 2001 May; 67(5):423-6. PubMed ID: 11381861 [Abstract] [Full Text] [Related]
16. Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis. Baltazard T, Dhaille F, Duvert-Lehembre S, Lok C, Chaby G. Dermatol Online J; 2017 Aug 15; 23(8):. PubMed ID: 29469749 [Abstract] [Full Text] [Related]
18. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens. Darling TN, Cardenas AA, Beard JS, Sau P, Yee CL, Zone JJ, Yancey KB. Arch Dermatol; 1995 Dec 15; 131(12):1438-42. PubMed ID: 7492135 [Abstract] [Full Text] [Related]
19. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis. Waldman MA, Black DR, Callen JP. Clin Exp Dermatol; 2004 Nov 15; 29(6):633-6. PubMed ID: 15550142 [Abstract] [Full Text] [Related]
20. Drug-induced linear IgA bullous dermatosis. Onodera H, Mihm MC, Yoshida A, Akasaka T. J Dermatol; 2005 Sep 15; 32(9):759-64. PubMed ID: 16361722 [Abstract] [Full Text] [Related] Page: [Next] [New Search]